Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Receivables (2016 - 2025)

Standard Biotools (LAB) has disclosed Change in Receivables for 16 consecutive years, with -$6.7 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 0.52% to -$6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 115.18% year-over-year, with the annual reading at $1.4 million for FY2025, 115.18% up from the prior year.
  • Change in Receivables for Q4 2025 was -$6.7 million at Standard Biotools, down from $5.8 million in the prior quarter.
  • The five-year high for Change in Receivables was $6.2 million in Q3 2022, with the low at -$11.4 million in Q3 2021.
  • Average Change in Receivables over 5 years is -$1.9 million, with a median of -$686000.0 recorded in 2024.
  • The sharpest move saw Change in Receivables soared 6013.33% in 2023, then tumbled 648.29% in 2024.
  • Over 5 years, Change in Receivables stood at -$11.4 million in 2021, then skyrocketed by 100.52% to $60000.0 in 2022, then skyrocketed by 6013.33% to $3.7 million in 2023, then crashed by 282.52% to -$6.7 million in 2024, then decreased by 0.52% to -$6.7 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$6.7 million, $5.8 million, and $276000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.